PathAI Public Market Comparables
Find the most relevant public market comparables for PathAI, including EV/Revenue and EV/EBITDA multiples to help you make informed investment decisions.
Company Overview
PathAI is a leading provider of integrated AI and digital pathology solutions dedicated to transforming diagnostic accuracy and operational efficiency in pathology labs worldwide. They develop AI-powered research tools and services for pathology, using machine learning to improve cancer diagnosis and treatment. The company offers biopharmacy lab services, clinical development services, drug and diagnostic development, and provides comprehensive precision pathology solutions from wet lab services to algorithm deployment for clinical trials and diagnostic use.
Business Model
PathAI operates on a business model that combines AI-powered software solutions with lab services. They offer AI-driven diagnostic tools and services to pathology labs, biopharmaceutical companies, and researchers. They also operate a CAP/CLIA-certified laboratory.
Target Customers
Pathology labs, biopharmaceutical companies, researchers, and hospitals.
Specific Focus
AI-powered digital pathology solutions
Location
Boston, Massachusetts
CEO
Andy Beck, MD, PhD
Industry
Life sciences
Sub Sector
Life Sciences/Biotechnology
3yr Revenue Growth
260%
Website
Public Market Comparables
Below are the key valuation metrics for companies similar to PathAI in the Healthcare sector. These metrics can help you understand how the market values companies with similar business models and growth profiles.
Looking for a comprehensive compset for PathAI? Our platform provides detailed analysis of PathAI's competitive landscape, including financial metrics, growth trends, and market positioning. Get access to the full PathAI compset by trying our platform today.
EV/Revenue Multiple
Min
0.0x
Median
0.0x
Max
00.0x
Unlock actual values by trying our platform
View Full DetailsEV/EBITDA Multiple
Min
00.0x
Median
00.0x
Max
00.0x
Unlock actual values by trying our platform
View Full Details
Unlock the Full PathAI Compset
As a leading player in the Life sciences industry within the Healthcare sector, PathAI operates in the specialized Life Sciences/Biotechnology sub-sector. Understanding how PathAI compares to its public market comps is essential for accurate valuation and strategic decision-making.
Our comprehensive analysis includes detailed comparables (compsets) featuring similar companies in the Life Sciences/Biotechnology space, with complete financial metrics, growth trajectories, and competitive positioning insights that go beyond the surface-level data shown above.
Other Interesting Companies
Aidoc
Healthcare • Software & services
Aidoc is a clinical AI company offering AI-driven solutions for analyzing medical imaging. Its platform assists in workflow management, identifies key findings, and coordinates care teams. Aidoc's solutions utilize deep learning and AI algorithms to detect critical anomalies in medical scans, improving diagnostic precision and streamlining abnormality identification.
Inotiv, Inc.
Pharmaceutical industry • Life sciences
Inotiv, Inc. is a leading contract research organization (CRO) providing nonclinical and analytical drug discovery and development services, research models, and related products and services. The company supports the discovery, nonclinical development, and clinical development needs of researchers and clinicians, primarily for small molecule drug candidates, biotherapeutics, and biomedical devices. They also sell research-quality animals and diets to pharmaceutical and medical device industries, academia, and government clients.
Tango Therapeutics, Inc.
Biotechnology • Life sciences
Tango Therapeutics is a clinical-stage biotechnology company dedicated to discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer. They leverage the genetic principle of synthetic lethality to discover and develop therapies targeting critical cancer targets.
Get Your Custom Comparable Analysis
Need a more detailed analysis of PathAI and its public market comparables? Our platform provides comprehensive valuation metrics, growth analysis, and more.
Try CompsetFinder Free